Cansortium Inc. (OTCMKTS:CNTMF – Get Rating) saw a significant increase in short interest in December. As of December 30th, there was short interest totalling 162,000 shares, an increase of 130.1% from the December 15th total of 70,400 shares. Based on an average trading volume of 461,700 shares, the short-interest ratio is currently 0.4 days.
Analysts Set New Price Targets
Separately, BTIG Research started coverage on Cansortium in a report on Friday, October 28th. They set a "buy" rating for the company.
Get
Cansortium alerts:
Cansortium Stock Performance
OTCMKTS CNTMF remained flat at $0.14 on Wednesday. The company's stock had a trading volume of 88,300 shares, compared to its average volume of 69,210. The stock's 50 day simple moving average is $0.15 and its two-hundred day simple moving average is $0.17. Cansortium has a 1-year low of $0.10 and a 1-year high of $0.68.
Cansortium Company Profile
(Get Rating)
Cansortium Inc, through its subsidiaries, produces and sells medical cannabis in the United States. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, and edibles under the Fluent brand name. Cansortium Inc was incorporated in 2018 and is headquartered in Miami, Florida.
Recommended Stories
- Get a free copy of the StockNews.com research report on Cansortium (CNTMF)
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
- Does it Matter Folks Aren't "Starry-Eyed" Over Pepsi's New Soda?
- Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.
去年12月,Cansortium Inc.(場外交易代碼:CNTMF-GET Rating)的空頭股數銷量大幅增長。截至12月30日,空頭股數共有162,000股,比12月15日的70,400股增加了130.1%。以46.17萬股的平均成交量計算,目前短息比為0.4天。
分析師設定新的價格目標
另外,BTIG Research在10月28日星期五的一份報告中開始報道Cansortium。他們為該公司設定了“買入”評級。
到達
Cansortium警報:
Cansortium股票表現
OTCMKTS CNTMF週三持平於0.14美元。該公司股票的成交量為88,300股,而其平均成交量為69,210股。該股的50日簡單移動均線切入位為0.15美元,200日簡單移動均線切入位為0.17美元。Cansortium的一年低點為0.10美元,一年高位為0.68美元。
Cansortium公司簡介
(獲取評級)
Cansortium Inc.通過其子公司在美國生產和銷售醫用大麻。該公司的醫用大麻產品以流利品牌名稱提供口服液、膠囊、外用藥物、注射器、乾花、預捲、藥筒和可食用產品。Cansortium Inc.成立於2018年,總部位於佛羅裡達州邁阿密。
推薦故事
- 免費獲取StockNews.com關於Cansortium的研究報告(CNTMF)
- 如新控股股票與沃倫·巴菲特有什麼關係?
- J.B.亨特買房,物流公司成為焦點
- 英特爾股票是否即將突破?
- 人們對百事可樂的新蘇打水不感興趣,這有什麼關係嗎?
- 強生的突破:盈利能提振股市嗎?
接受Cansortium Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cansortium和相關公司的最新新聞和分析師評級的每日簡要摘要。